XML 47 R24.htm IDEA: XBRL DOCUMENT v3.25.0.1
Note 16 - Stock-Based Compensation
12 Months Ended
Dec. 31, 2024
Notes to Financial Statements  
Stock-Based Compensation

Note 16. Stock-Based Compensation

The Company’s board of directors adopted in February 2010, and its stockholders approved in May 2010, the QCR Holdings, Inc. 2010 Equity Incentive Plan (“2010 Equity Incentive Plan”). The Company’s board of directors adopted in February 2013, and its stockholders approved in May 2013, the QCR Holdings, Inc. 2013 Equity Incentive Plan (“2013 Equity Incentive Plan”). The Company’s board of directors adopted in February 2016, and its stockholders approved in May 2016, the QCR Holdings, Inc. 2016 Equity Incentive Plan (“2016 Equity Incentive Plan”). The Company’s board of directors adopted in February 2024, and its stockholders approved in May 2024, the QCR Holdings, Inc. 2024 Equity Incentive Plan (“2024 Equity Incentive Plan”). Up to 350,000, 350,000, 400,000 and

Note 16. Stock-Based Compensation (continued)

600,000 shares of common stock, respectively, may be issued to employees and directors of the Company and its subsidiaries pursuant to equity incentive awards granted under these plans.

The 2010 Equity Incentive Plan, the 2013 Equity Incentive Plan,  the 2016 Equity Incentive Plan and the 2024 Equity Incentive Plan (collectively, the “Equity Plans”) are administered by the Compensation Committee of the board of directors (the “Committee”). As of December 31, 2024, there were 622,344 remaining shares of common stock available for the grant of future awards under the Equity Plans; however, such future awards may be granted only under the 2024 Equity Incentive Plan.

The number and exercise price of options granted under the Equity Plans are determined by the Committee at the time the option is granted. In no event can the exercise price be less than the value of the common stock at the date of the grant for stock options. All options have a 10-year life and will vest and become exercisable from 3-to-7 years after the date of the grant. The value of restricted stock awards is estimated by using the market price of the Company’s common stock at the date of grant.

Stock-based compensation expense was reflected in the Consolidated Financial Statements as follows for the years ended December 31, 2024, 2023, and 2022.

    

2024

    

2023

    

2022

(dollars in thousands)

Stock options

$

358

$

286

$

246

Restricted stock awards

2,128

2,084

1,967

Stock purchase plan

 

339

 

308

 

225

$

2,825

$

2,678

$

2,438

Stock options:

A summary of the stock option plans as of December 31, 2024, 2023, and 2022 and changes during the years then ended is presented below:

December 31, 

2024

2023

2022

Weighted

Weighted

Weighted

Average

Average

Average

Exercise

Exercise

Exercise

    

Shares

    

Price

    

Shares

    

Price

    

Shares

    

Price

Outstanding, beginning

290,149

$

32.11

346,678

$

27.60

367,998

$

24.46

Granted

 

29,900

 

56.79

 

25,000

 

53.31

 

22,400

 

53.87

Exercised

 

(95,724)

 

22.05

 

(81,354)

 

19.45

 

(41,695)

 

14.07

Forfeited

 

(3,479)

 

39.01

 

(175)

 

15.65

 

(2,025)

 

26.72

Outstanding, ending

 

220,846

 

39.70

 

290,149

 

32.11

 

346,678

 

27.60

 

  

 

  

 

  

 

  

 

  

 

  

Exercisable, ending

 

158,911

 

  

 

233,967

 

  

 

295,077

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Weighted average fair value per option granted

$

18.61

 

  

$

16.36

 

  

$

13.97

 

  

Note 16. Stock-Based Compensation (continued)

A further summary of options outstanding as of December 31, 2024 is presented below:

Options Outstanding

Weighted

Options Exercisable

Average

Weighted

Weighted

Remaining

Average

Average

Range of

Number

Contractual

Exercise

Number

Exercise

Exercise Prices

    

Outstanding

    

Life

    

Price

    

Exercisable

    

Price

$17.49 to $17.86

23,869

0.09

$

17.49

23,869

$

17.49

$21.71 to $22.64

 

44,123

 

1.09

 

22.64

 

44,123

 

22.64

$29.77 to $36.00

 

12,875

 

4.17

 

36.00

 

12,875

 

36.00

$40.00 to $41.95

 

13,602

 

5.17

 

40.00

 

13,602

 

40.00

$42.65 to $48.50

 

53,428

 

3.78

 

43.85

 

48,506

 

43.88

$53.31 to $56.79

 

72,949

 

8.29

 

54.85

 

15,936

 

53.70

 

220,846

 

  

 

  

 

158,911

 

  

 

 

  

Restricted stock and unit awards:

A summary of changes in the Company’s nonvested restricted stock, restricted stock unit and performance stock unit awards as of December 31, 2024, 2023 and 2022 is presented below:

December 31, 

    

2024

    

2023

    

2022

Outstanding, beginning

88,178

84,115

97,107

Granted*

 

28,211

 

51,157

 

35,525

Released

 

(43,468)

 

(43,331)

 

(47,766)

Forfeited

 

(5,297)

 

(3,763)

 

(751)

Outstanding, ending

67,624

88,178

84,115

Weighted average fair value per share granted

$

58.01

$

51.64

$

54.20

*  At December 31, 2024, includes 1,500 shares of restricted stock and 64,620 restricted stock units.

At December 31, 2023, includes 4,500 shares of restricted stock and 80,820 restricted stock units.

At December 31, 2022, includes 8,527 shares of restricted stock and 64,494 restricted stock units.

The total grant value of restricted stock, restricted stock unit and performance share unit awards that were released during the years ended December 31, 2024, 2023 and 2022 was $2.6 million, $2.2 million and $2.6 million, respectively.

Note 16. Stock-Based Compensation (continued)

Employee stock purchase plan:

On May 19, 2022, the Company’s stockholders approved the QCR Holdings, Inc. 2022 Stock Purchase Plan (the “2022 Purchase Plan”). The 2022 Purchase Plan has an effective date of July 1, 2022 and a share reserve equal to 350,000 shares plus the shares remaining under the QCR Holdings, Inc. Amended and Restated Employee Stock Purchase Plan immediately prior to its termination on July 1, 2022. As of January 1, 2025, there were 317,068 shares of common stock available for issuance under the 2022 Purchase Plan. For each six-month offering period, the board of directors will determine how many of the total number of available shares will be offered. The purchase price is the lesser of 85% or the fair market value at the date of the grant or the investment date. The investment date, as established by the board of directors, is the date common stock is purchased after the end of each calendar quarter during an offering period. The maximum dollar amount any one participant can elect to contribute in a year is $21,250.

Additionally, the maximum percentage that any one participant can elect to contribute is 15% of his or her compensation for the years ended December 31, 2024, 2023 and 2022.  Information for the stock purchase plan for the years ended December 31, 2024, 2023 and 2022 is presented below:

    

2024

    

2023

    

2022

Shares granted

 

28,746

 

36,964

 

28,421

Shares purchased

 

31,069

 

35,058

 

27,103

Weighted average fair value per share granted

$

11.85

$

8.35

$

7.88